Prof. Erika Lietzan

Professor Lietzan Participates in Center for the Protection of Intellectual Property Summer Institute

July 21st, 2017

Professor Erika Lietzan recently attended the 2017 Summer Institute, hosted by the Center for the Protection of Intellectual Property at Antonin Scalia Law School, George Mason University. She presented “The Drug Innovation Paradox,” which will be published

Read More

Objective Intent: Professor Lietzan’s New Blog Focuses on Food and Drug Administration

July 13th, 2017

Professor Erika Lietzan has launched a new blog, Objective Intent. In this blog, she and a co-author, Professor Patricia Zettler of Georgia State University, explore legal and policy issues associated with the U.S. Food and Drug Administration

Read More

Professor Lietzan Publishes Essay on Supreme Court Decision in Sandoz v. Amgen

June 21st, 2017

This heavily-anticipated decision related to patent disputes between the developers of new biological medicines and the manufacturers of “biosimilar” copies of those medicines.

Professor Lietzan Named Affiliate Scholar of Center for the Protection of Intellectual Property

June 7th, 2017

Professor Erika Lietzan has been named an Affiliate Scholar at the Center for the Protection of Intellectual Property, part of George Mason University’s Antonin Scalia Law School. She is also currently the recipient of an Thomas Edison

Read More

Professor Lietzan to Attend Economics Institute for Law Professors

May 17th, 2017

Professor Erika Lietzan was selected to attend the Thirty-Third Economics Institute for Law Professors, hosted by the Henry G. Manne Program in Law and Economic Studies at the Antonin Scalia Law School at George Mason University. Professor

Read More